NewsAP via Fox News, unofficialNov 6, 2026 · 10 min read

Massachusetts and Idaho Marijuana Measures Failed, AP Reports. What a No Vote Did Not Do

Massachusetts Question 8 and Idaho HJR 4 both failed in unofficial AP counts shown by Fox News on Nov. 6. Neither state's database showed certified totals. Here is what a no vote left in place, what it did not do, and what to check.

Massachusetts and Idaho Marijuana Measures Failed, AP Reports. What a No Vote Did Not Do

Did the Nov. 3 votes change marijuana law in Massachusetts or Idaho? On the counts available so far, no. The Associated Press has both measures failing, in unofficial figures shown by Fox News on Nov. 6: Massachusetts Question 8 at 75.57% no and Idaho HJR 4 at 66.27% no. A failed measure adds no new right, so Idaho legalized nothing; the Idaho Capital Sun reports marijuana remains illegal there. Neither state's results database showed certified totals when we checked.

What voters did on Nov. 3

The Associated Press count shown by Fox News on Nov. 6 had Massachusetts Question 8 at 1,962,147 no (75.57%) to 634,159 yes (24.43%), with 97.61% reporting. AP's Idaho count on Fox News the same morning had HJR 4 at 471,321 no (66.27%) to 239,906 yes (33.73%), with 98.58% reporting. Both are unofficial.

75.57% no
Massachusetts Question 8. Unofficial, AP via Fox News, Nov. 6
97.61%
Reporting in Massachusetts. Unofficial, AP via Fox News, Nov. 6
66.27% no
Idaho HJR 4. Unofficial, AP via Fox News, Nov. 6
98.58%
Reporting in Idaho. Unofficial, AP via Fox News, Nov. 6

AP called Massachusetts around midnight, with about 48% counted, Boston.com reported. It called Idaho at 10:39 p.m. Mountain time on election night, the Idaho Capital Sun reported in a story republished on Yahoo. No led in all 44 Idaho counties on the Nov. 4 count, CBS2 reported. Those are calls and unofficial tallies, not certifications.

Neither state's results database listed these votes when we checked on Nov. 6: the Massachusetts PD43+ ballot question search and the State of Idaho Elections Database both showed no 2026 rows. Both are archives of past elections, so a gap this soon after the vote is not surprising, and it says nothing about the outcome. It does mean no state record we could read documents either 2026 result yet.

Diagram of three steps, race call, unofficial count and state certification, showing Massachusetts and Idaho both at the unofficial count step on Nov. 6, 2026. Labeled unofficial.
Calling a race and certifying it are separate steps. Status as of Nov. 6, 2026, from AP via Fox News, Boston.com, the Idaho Capital Sun and each state's results database.

The two votes, side by side

Put together, on AP's unofficial counts, these votes share one feature: each no left a law where it was. The table gives each measure as the Boston Globe's Nov. 4 report, Boston.com's Oct. 5 explainer and the Idaho Capital Sun described it. We could not read either text, so the descriptions are theirs.

Massachusetts Question 8Idaho HJR 4
What a yes would have done, as reportedBoston Globe: adult-use shops close by the start of 2028 or become medical dispensaries; the medical market is unaffected; adults could still possess or gift up to an ounceIdaho Capital Sun: only the Legislature could legalize marijuana and other drugs, with no voter initiatives on them
What a no leaves in place, as reportedBoston.com: existing laws, with sales continuing. Those laws are the adult-use law as amended in April 2026Idaho Capital Sun: voters keep the initiative power, and marijuana and cannabis remain illegal
Unofficial count, Nov. 675.57% no, 24.43% yes, 97.61% reporting66.27% no, 33.73% yes, 98.58% reporting
Official statusUnofficial. No 2026 row in PD43+ on Nov. 6. We found no confirmed certification dateUnofficial. No 2026 row in the Idaho Elections Database on Nov. 6. The Idaho Capital Sun reports the State Board of Canvassers meets Nov. 24
Massachusetts Question 8 and Idaho HJR 4 as reported. Counts are unofficial, AP via Fox News, Nov. 6, 2026.

Massachusetts: a no vote on a law already amended in April

One point stays unresolved: home growing. The Globe said Question 8 would have stripped away protections for growing at home, and Boston.com said it would have repealed the laws permitting it. WBUR's Oct. 9 explainer said home cultivation would remain legal. We could not read the measure's text, so we are not settling that here. The conflict is about what a yes would have done, not about the count.

The more practical change for a Massachusetts adult came before the election. The law a no left in place is not the 2016 law as voters passed it. The Massachusetts Cannabis Control Commission describes Ch. 65 of the Acts of 2026 as "a new state law that restructured the Commission and changed cannabis laws" in its Oct. 8 statement. The April law raised the limit from one ounce to two for adults without medical cards, the Globe reported. We could not open the act itself, so treat any summary of it, including this one, as a pointer to the text.

Regulation keeps moving on its own track. The Commission said on Oct. 22 it would discuss draft testing regulations at its next public meeting on Nov. 12. That is a draft, not a rule. In September it said it planned a December vote on three sets of draft regulations, then public comment and a hearing. The Globe reported that its chair said the work continues. We found no Commission statement on the result as of Nov. 6.

The Commission's Oct. 8 statement, which predates the vote, said that a decade on, the industry has generated $10 billion in gross sales. It counted nearly 800 operating businesses and reported $285 million in fiscal 2026 state excise and sales tax. Our explainer on how states tax cannabis is general background and does not cover Massachusetts.

Idaho: reported as a vote about who may legalize, not about legality

As the Idaho Capital Sun reported it, HJR 4 would have left only the Legislature able to legalize marijuana and other drugs, ending voter initiatives on them. KTVB reported that it did not itself legalize anything. On those descriptions, a vote against it was about who decides, not a vote for legal marijuana. Marijuana and cannabis remain illegal in Idaho, the Capital Sun reported, and voters retain their initiative power. We could not open the Idaho Code or the resolution, so that statement is the paper's.

Marijuana Moment reported on July 14, quoting the Secretary of State, that a 2026 medical marijuana initiative failed to qualify. It gave the requirement as 6%, or 70,725 signatures, in 18 of 35 districts. The campaign disputed that, and we do not know where the dispute stands now. That drive is separate from HJR 4.

What changed, and what neither vote touched

What changed: if certification matches AP's counts, two proposals failed and neither wrote anything into law. What did not change is the longer list.

  • Massachusetts law. A failed repeal changes nothing in the statute it targeted and adds no new right. The Commission says Ch. 65 had already changed the state's cannabis laws.
  • Idaho law. HJR 4 was reported as a change to who may legalize. Its failure legalizes nothing.
  • Federal marijuana status. Marijuana remains a controlled substance under federal law. A state vote does not change that.
  • Federal hemp law. Neither vote touched it.
  • CBD rules. A measure that fails creates no new rule, so neither vote added one for CBD.
  • Other states. Neither result binds any other state.

On the federal side, the Schedule III order published April 28 covers state-licensed medical marijuana and FDA-approved products. As of Nov. 6 we found no final rule on adult-use marijuana in the Federal Register. Our report on the appeals court order follows what is still pending.

Federal hemp timing runs on its own calendar. One narrow exclusion still arrives Nov. 12, for cannabinoids "not capable of being naturally produced by a Cannabis sativa L. plant" and nothing broader. The rest of Section 781 of P.L. 119-37 waits until after Dec. 11, under timing set by P.L. 119-103. Our breakdown of the two hemp deadlines has the detail, and the federal rule and state exceptions for CBD live in our hub.

Why the numbers keep moving

If you saw 76-24 or 66-34 earlier in the week, that was an earlier unofficial snapshot, not an error. The shares barely moved as the count grew. The yardsticks differ, though: Fox's table says percent reporting, while Marijuana Moment's Idaho report used AP's estimated share of ballots counted. Those are not one series. KTVB's Nov. 4 report said "more than 67%" voted against HJR 4, citing unofficial results without naming who compiled them; later AP figures do not match it.

StateAs ofReported byNoYesCounted
MassachusettsAbout midnight, Nov. 4AP race call, per Boston.comNearly 76%About 24%About 48%
MassachusettsMorning, Nov. 4Boston GlobeAround 76%About 24%Close to 90%
MassachusettsNov. 6, 7:14 a.m. ETAP via Fox News1,962,147 (75.57%)634,159 (24.43%)97.61% reporting
Idaho2:20 a.m. MT, Nov. 4Idaho Capital Sun425,809 (66.1%)218,312 (33.9%)Still counting
IdahoMorning, Nov. 4AP via Marijuana Moment66%34%Estimated 94%
IdahoNov. 6, 7:17 a.m. ETAP via Fox News471,321 (66.27%)239,906 (33.73%)98.58% reporting
How the counts moved. Every row is unofficial. The Nov. 6 rows are the latest we read.
Dot chart of the unofficial no share in Massachusetts and Idaho at three reported points each from Nov. 4 to Nov. 6, 2026, with each state's dots nearly level. Labeled unofficial, as reported.
The share barely moved as the count grew. All figures unofficial, as reported by the outlets named in the table above, through Nov. 6, 2026.

For comparison, the state's own record shows 2016 Question 4 passing with 1,769,328 yes votes to 1,528,219 no. By our arithmetic that is 53.7% of yes and no votes, or 52.4% of all ballots counting blanks. That record is final and this year's count is not, so hold any direct comparison until certification. Our dated history of cannabis law gives the longer context.

What to check before you rely on this

  1. 1Look for the word certified. Until a state certifies, treat every count as unofficial.
  2. 2Check the date and the source on any figure, and prefer the latest dated one.
  3. 3In Massachusetts, read the current law. A summary written before April 2026 may predate Ch. 65.
  4. 4Treat the reporting on what Question 8 would have done to home growing as unsettled until you have read the measure. For today's rules, read the statute.
  5. 5For your own situation, ask your state regulator or a lawyer who practices in your state.

Dates to watch, as of Nov. 6. The two Nov. 12 items are unrelated: one is a Massachusetts agency meeting, the other a federal statute.

  • Nov. 12: the Cannabis Control Commission meets, with draft testing regulations up for discussion.
  • Nov. 12: the narrow federal hemp exclusion takes effect.
  • Nov. 24: Idaho's State Board of Canvassers meets, the Idaho Capital Sun reports, and the paper says results are not official until the board certifies them.
  • December: the Commission plans its vote on draft regulations.
  • Dec. 11: the date set by P.L. 119-103. The rest of Section 781 waits until after it.

Questions readers are asking

The reporting says a no keeps it in place: Boston.com's Oct. 5 explainer said a no would keep existing laws, with sales continuing. The law in question is the state's adult-use law as amended in April 2026, not the 2016 text alone. The vote figures are unofficial, and this is not legal advice.

No. KTVB reported that HJR 4 did not itself legalize anything, so voting it down could not have done so either. The Idaho Capital Sun reported that marijuana and cannabis remain illegal in Idaho.

Nothing is added to the law. If AP's unofficial result is certified, the shift to Legislature-only legalization that the Idaho Capital Sun described does not happen, and the paper reports voters retain their initiative power.

No. The Idaho Capital Sun reports that Idaho's results are not official until the State Board of Canvassers certifies them, and that it meets Nov. 24. We found no confirmed date for Massachusetts. Neither state's database showed a 2026 ballot question row on Nov. 6.

No. A measure that fails creates no new rule, and a state vote cannot change federal hemp law. One narrow federal exclusion still arrives Nov. 12, and the rest waits until after Dec. 11.

If your question is about CBD and not marijuana, these two votes do not change the answer. The page to keep is our guide to whether CBD is legal, with its state exceptions and flying rules.

#Massachusetts#Idaho#Ballot measures#Marijuana law#Hemp law
P
Planntz Editorial Team
Editorial team

Writing about hemp, wellness and the small rituals that keep us balanced.

Latest news

From the newsroom

Adding Mindfulness to an Online Cannabis Program: What a 301-Person Trial FoundInternet Interventions01

Adding Mindfulness to an Online Cannabis Program: What a 301-Person Trial Found

A Swiss trial of 301 frequent cannabis users tested mindfulness added to an automated online CBT program. At 6 months it was associated with about half as many reported use days as CBT alone, but only 95 people were measured and we found no English version.

Nov 14, 2026·15 min read
Cannabis and Sperm Meta-Analysis: Shape Differed, Count Did NotInternational Brazilian Journal of Urology02

Cannabis and Sperm Meta-Analysis: Shape Differed, Count Did Not

A meta-analysis of 18 studies, indexed November 11, 2026, found men who smoked cannabis had slightly lower normal sperm morphology and higher SHBG. Count, motility, testosterone, FSH and LH showed no significant difference. It shows an association, not a cause.

Nov 12, 2026·11 min read
Do Women Feel THC More? In a 44-Person Trial, Occasional-Use Men Felt It MostNeuropsychopharmacology03

Do Women Feel THC More? In a 44-Person Trial, Occasional-Use Men Felt It Most

A UCLA placebo-controlled trial published October 29, 2026 gave 44 adults smoked cannabis at 0%, 4% and 10% THC. Women did not report stronger effects than men; occasional-use men reported the most unpleasant ones. Frequency findings were exploratory.

Oct 31, 2026·14 min read
HHS Proposes Changes to Federal Drug Testing: What Changes, and What Stays the Same for THC and CBDU.S. Department of Health and Human Services, SAMHSA (Federal Register 2026-22122)04

HHS Proposes Changes to Federal Drug Testing: What Changes, and What Stays the Same for THC and CBD

HHS proposed revisions to the federal workplace drug-testing guidelines on October 29, 2026. Most changes are lab mechanics. Marijuana stays on every test, cutoffs do not move, and secondhand smoke is still not an accepted explanation. Comments close December 28.

Oct 30, 2026·10 min read
A Pilot Trial Gave Knee-Replacement Patients Prescription CBD. It Missed Its Main Goal.J Pain05

A Pilot Trial Gave Knee-Replacement Patients Prescription CBD. It Missed Its Main Goal.

On October 22, 2026, The Journal of Pain published a triple-blind pilot trial of prescription CBD in 36 knee-replacement patients. Neither dose significantly changed 72-hour opioid use. A post hoc signal at 400 mg needs a larger trial; 800 mg brought more side effects.

Oct 24, 2026·18 min read
Cochrane Reviewed Medical Cannabis for Insomnia: What It Found, and What It Could Not TestCochrane Database of Systematic Reviews (CD016216, 2026)06

Cochrane Reviewed Medical Cannabis for Insomnia: What It Found, and What It Could Not Test

On October 13, 2026, Cochrane pooled 9 randomized trials in 537 adults with insomnia. Medical cannabis may have little to no clinically meaningful effect on sleep, on very low-certainty evidence, with more adverse events (low certainty).

Oct 13, 2026·15 min read
DEA Proposes a New 7-OH Threshold and Withdraws the July One: What Changes, and WhenU.S. Drug Enforcement Administration (Federal Register 2026-20943)07

DEA Proposes a New 7-OH Threshold and Withdraws the July One: What Changes, and When

On October 9, 2026, DEA filed a notice of intent proposing a new 7-OH threshold: more than 1 mg per gram or per mL, or a mitragynine ratio under 100. DEA says it is withdrawing the July 6 version. No order can issue before November 13, 2026.

Oct 10, 2026·16 min read
FDA Drops Premarket Review for Federal Drug-Test Devices: What Changed, and What Did NotU.S. Food and Drug Administration (Federal Register 2026-20448)08

FDA Drops Premarket Review for Federal Drug-Test Devices: What Changed, and What Did Not

On October 6, 2026, FDA let drug-test systems in 14 categories, including cannabinoid tests, skip 510(k) review for federal programs. Saliva testing for DOT jobs is still not here: HHS's latest list shows no certified oral-fluid lab.

Oct 6, 2026·14 min read
WADA's 2027 Cannabinoid Rule: CBD Is Still Allowed, and the Blanket Clause Is GoneWorld Anti-Doping Agency09

WADA's 2027 Cannabinoid Rule: CBD Is Still Allowed, and the Blanket Clause Is Gone

WADA published its 2027 Prohibited List on September 21, 2026. CBD is still not prohibited and THC still is, in-competition. The sentence that banned all natural and synthetic cannabinoids is gone, and WADA has not said what that means for CBG, CBN or THCV.

Sep 23, 2026·18 min read
An Appeals Court Left Medical Marijuana in Schedule III. It Did Not Decide the CaseU.S. Court of Appeals, D.C. Circuit010

An Appeals Court Left Medical Marijuana in Schedule III. It Did Not Decide the Case

On September 9, 2026 the D.C. Circuit denied a stay of the April order placing state-licensed medical marijuana in Schedule III. The challenges are still pending, broader rescheduling is still a proposal, and the rule says it does not affect hemp.

Sep 14, 2026·17 min read
A Randomized Trial Gave 18 Adults 12.5 mg of THC, With and Without CBD. Both Oils Raised Heart Rate.Br J Clin Pharmacol011

A Randomized Trial Gave 18 Adults 12.5 mg of THC, With and Without CBD. Both Oils Raised Heart Rate.

A randomized, double-blind crossover trial published on August 27, 2026 gave 18 healthy adults 12.5 mg of THC, with and without 12.5 mg of CBD, then made them breathe against a resistance. Both oils raised heart rate. Here is what the record supports and what it does not.

Sep 12, 2026·20 min read
A Trial Tested CBD Ads. The Control Group Is the StoryClinicalTrials.gov012

A Trial Tested CBD Ads. The Control Group Is the Story

On August 28, 2026 results were posted for a randomized trial that put 460 shoppers through a simulated mini mart. In the room with no CBD advertising at all, shoppers endorsed 5.6 of 12 listed benefits and 163 of 230 bought a CBD-branded product anyway.

Sep 7, 2026·23 min read
The FDA GRAS Proposal: How a New Ingredient Reaches a Shelf, and Why It Names Delta-8 THCFederal Register013

The FDA GRAS Proposal: How a New Ingredient Reaches a Shelf, and Why It Names Delta-8 THC

On August 11, 2026 FDA proposed making GRAS notification mandatory, and it names Delta-8 THC foods among its five examples. It is a proposal: comments close December 9, 2026, two days before the federal hemp-definition change takes effect.

Sep 6, 2026·25 min read
DEA Scheduled Three Kratom Analogs on August 26. It Did Not Schedule 7-OHFederal Register014

DEA Scheduled Three Kratom Analogs on August 26. It Did Not Schedule 7-OH

On August 26, 2026 DEA placed three kratom-derived analogs in Schedule I by temporary order: mitragynine pseudoindoxyl, MGM-15 and MGM-16. It did not schedule 7-hydroxymitragynine and it did not name kratom leaf. The HHS comment window closes September 10, 2026.

Sep 4, 2026·25 min read
Congress Moved the Hemp Deadline to December 11, and Left One Piece on November 12The White House015

Congress Moved the Hemp Deadline to December 11, and Left One Piece on November 12

On September 2, 2026 a single-sentence section inside H.R. 6500 split the 2026 hemp deadline in two. Most of the new definition now arrives on December 11, 2026. One exclusion still arrives on November 12, and it is the one whose official list does not exist.

Sep 3, 2026·23 min read